Thoracic Surgery

Randomized Trial: Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

13 Dec, 2018 | 19:05h | UTC

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Durvalumab After Chemoradiation for Advanced Non–Small-Cell Lung Cancer – NEJM Journal Watch (free) AND Durvalumab Shows Overall Survival Benefit in Patients With Stage III NSCLC – Cancer Therapy Advisor (free)

 

---

Consensus: Use of Antibacterial Drugs in Thoracic Surgery

13 Dec, 2018 | 19:03h | UTC

Society for Translational Medicine expert consensus on the use of antibacterial drugs in thoracic surgery – Journal of Thoracic Disease (free)

 

---

Review: Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer

13 Dec, 2018 | 18:50h | UTC

Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer – Chest (free)

 

---

Randomized Trial: Therapies for Small-Cell Lung Cancer Compared

13 Dec, 2018 | 18:00h | UTC

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Quick Take Video Summary: Combined Therapies for Small-Cell Lung Cancer – New England Journal of Medicine (free)

 

---

SEOM Guideline: Treatment of Non-small Cell Lung Cancer

25 Nov, 2018 | 20:38h | UTC

SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018) – Clinical and Translational Oncology (free)

 

---

Position Statement: Recommendations on the Use of Ultrasound Guidance for Adult Thoracentesis

23 Nov, 2018 | 00:20h | UTC

Recommendations on the Use of Ultrasound Guidance for Adult Thoracentesis: A Position Statement of the Society of Hospital Medicine – Journal of Hospital Medicine (free)

 

---

Things We Do for No Reason: Routine Chest Radiographs after Uncomplicated Thoracentesis

23 Nov, 2018 | 00:10h | UTC

Routine Chest Radiographs after Uncomplicated Thoracentesis – Journal of Hospital Medicine (free PDF)

 

---

Comprehensive Review of Fetal Adenocarcinoma of the Lung

22 Nov, 2018 | 21:33h | UTC

Comprehensive review of fetal adenocarcinoma of the lung – Lung Cancer: Targets and Therapy (free)

 

---

Review: Silicosis and Lung Cancer

22 Nov, 2018 | 21:34h | UTC

Silicosis and lung cancer: current perspectives – Lung Cancer: Targets and Therapy (free)

 

---

NCCN Guideline: Small Cell Lung Cancer

17 Oct, 2018 | 13:42h | UTC

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. – Journal of the National Comprehensive Cancer Network (free)

 

---

Guideline: Management of Malignant Pleural Effusions

5 Oct, 2018 | 02:21h | UTC

Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine (free)

Related Guideline: ERS/EACTS statement on the management of malignant pleural effusions – European Respiratory Journal (free)

 

---

Study: CT Screening for Early Lung Cancer Reduces Lung Cancer Mortality

5 Oct, 2018 | 01:31h | UTC

WCLC 2018: NELSON Study: CT Screening for Early Lung Cancer Reduces Lung Cancer Mortality – The ASCO Post (free)

Related: NELSON lung cancer study encourages widespread screening, Medicare reimbursement – Health Imaging (free) AND Second Large Study Shows That Lung Cancer Screening Works – Medscape (free registration required)

 

---

Study: Deep Learning Algorithm for Detection of Malignant Pulmonary Nodules on Chest Radiographs

27 Sep, 2018 | 23:04h | UTC

Development and Validation of Deep Learning–based Automatic Detection Algorithm for Malignant Pulmonary Nodules on Chest Radiographs – Radiology (link to abstract – $ for full-text)

Commentary: Deep learning algorithm detects malignant pulmonary nodules better than radiologists – Radiology Business (free)

Related Studies: Deep Learning for the Diagnosis of Fibrotic Lung Disease (link to abstract and commentaries) AND Can Artificial Intelligence Reliably Report Chest X-Rays? (free study and commentaries) AND Artificial Intelligence Can Determine Lung Cancer Type (link to abstract and commentaries)

 

---

Study: Artificial Intelligence Can Determine Lung Cancer Type

20 Sep, 2018 | 19:47h | UTC

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning – Nature Medicine (link to abstract – $ for full-text)

Commentaries: Artificial intelligence can determine lung cancer type – eCancer News (free) AND Google AI Tool Identifies a Tumor’s Mutations From An Image – WIRED (free)

 

---

Guideline: Clinical Imaging for Hemoptysis

6 Sep, 2018 | 02:48h | UTC

2018 Korean Clinical Imaging Guideline for Hemoptysis – Korean Journal of Radiology (free)

 

---

Guideline: Management of Malignant Pleural Effusions

31 Aug, 2018 | 02:48h | UTC

ERS/EACTS statement on the management of malignant pleural effusions – European Respiratory Journal (free)

 

---

Summary: ASCO Guideline for the Management of Malignant Pleural Mesothelioma

26 Jul, 2018 | 17:34h | UTC

Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment – Journal of Thoracic Disease (free)

 

---

Consensus: Immunotherapy for the Treatment of Non-small Cell Lung Cancer

20 Jul, 2018 | 01:56h | UTC

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC) – Journal for ImmunoTherapy of Cancer (free)

 

---

NCCN Guideline Update: Non–Small Cell Lung Cancer

20 Jul, 2018 | 01:46h | UTC

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018 – Journal of the National Comprehensive Cancer Network (free)

 

---

Liquid Biopsy: Still Early Days for Early Detection

13 Jul, 2018 | 01:31h | UTC

Liquid biopsy: still early days for early detection – The Lancet (free registration required)

 

---

Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer

13 Jul, 2018 | 01:12h | UTC

IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC) – Journal of Thoracic Oncology (free PDF)

Commentary: IASLC Issues Statement Paper on Liquid Biopsy for Lung Cancer – The ASCO Post (free)

 

---

Randomized Trial: Treatments for Metastatic Nonsquamous NSCLC Compared

15 Jun, 2018 | 01:16h | UTC

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: ASCO 2018: First-Line Atezolizumab Improves Survival in Advanced NSCLC – European Society of Medical Oncology (free)

 

---

ASCO 2018: Pembrolizumab vs. Chemotherapy as First-line Therapy for Advanced Non-Small Cell Lung Cancer

7 Jun, 2018 | 02:20h | UTC

Pembrolizumab (pembro) versus platinum-based chemotherapy (chemo) as first-line therapy for advanced/metastatic NSCLC with a PD-L1 tumor proportion score (TPS) ≥ 1%: Open-label, phase 3 KEYNOTE-042 study (link to abstract)

Commentaries: 2018 ASCO: KEYNOTE-042 Trial Compares Pembrolizumab With Chemotherapy as First-Line Treatment of NSCLC With PD-L1 Expression of 1% or More – The ASCO Post (free) AND ‘End of an Era’ for Chemo in Non-Small Cell Lung Cancer – Medscape (free registration required)

 

---

Cohort Study: Lifetime Smoking History and Risk of Lung Cancer

1 Jun, 2018 | 04:14h | UTC

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study – Journal of the National Cancer Institute (link to abstract – $ for full-text)

Commentaries: Risk of Incident Lung Cancer Drops by 39% Five Years After Smokers Quit – AJMC (free) AND New research finds lung cancer risk drops substantially within five years of quitting – Vanderbilt University Medical Center, via eCancer News (free)

 

---

Review: Management Pathways for Solitary Pulmonary Nodules

24 May, 2018 | 22:41h | UTC

Management pathways for solitary pulmonary nodules – Journal of Thoracic Disease (free)

 

---